NICE widens somatropin recommendations for children
This article was originally published in Scrip
Executive Summary
NICE, the National Institute for health and Clinical Excellence, has recommended two new indications for the recombinant human growth hormone somatropin when used to treat growth failure in children on the NHS in England and Wales.